Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
J L Misset, V Dieras, G Gruia, et al.
Diseases of the Colon and Rectum
|
February 1, 1991
A rare cause of colitis--Brucella melitensis. Report of a case
P G Jorens, P P Michielsen, E J Van den Enden, et al.
BMC Cancer
|
October 24, 2021
Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol
M Chartogne, A Leclercq, B Beaune, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience
J Bonneterre, M Spielman, J P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2018
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy, et al.
British Journal of Cancer
|
September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
P Harter, C Marth, M-A Mouret-Reynier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
H Bourgeois, F Grudé, P Solal-Céligny, et al.
Oncologie (Paris, France)
|
July 21, 2015
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (<i>Observatoire dédié au Cancer Bretagne / Pays de la Loire</i>)
J P Metges, M A Lebot, R Faroux, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
J L Misset, V Dieras, G Gruia, et al.
Diseases of the Colon and Rectum
|
February 1, 1991
A rare cause of colitis--Brucella melitensis. Report of a case
P G Jorens, P P Michielsen, E J Van den Enden, et al.
BMC Cancer
|
October 24, 2021
Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol
M Chartogne, A Leclercq, B Beaune, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience
J Bonneterre, M Spielman, J P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2018
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
J Cortes, J Perez-Garcia, C Levy, et al.
British Journal of Cancer
|
September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
P Harter, C Marth, M-A Mouret-Reynier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
H Bourgeois, F Grudé, P Solal-Céligny, et al.
Oncologie (Paris, France)
|
July 21, 2015
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (<i>Observatoire dédié au Cancer Bretagne / Pays de la Loire</i>)
J P Metges, M A Lebot, R Faroux, et al.
Page
of 7